The estimated Net Worth of David W. Truetzel is at least $21 dollars as of 29 November 2022. Mr. Truetzel owns over 67 units of SINTX Technologies Inc stock worth over $13 and over the last 9 years he sold SINT stock worth over $8. In addition, he makes $0 as Independent Director at SINTX Technologies Inc.
Sign up
Mr. Truetzel SINT stock SEC Form 4 insiders trading
David has made over 2 trades of the SINTX Technologies Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 67 units of SINT stock worth $8 on 29 November 2022.
The largest trade he's ever made was selling 20,625 units of SINTX Technologies Inc stock on 9 December 2015 worth over $67,856. On average, David trades about 5,173 units every 637 days since 2015. As of 29 November 2022 he still owns at least 4 units of SINTX Technologies Inc stock.
You can see the complete history of Mr. Truetzel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Truetzel biography
David W. Truetzel, CPA., is Independent Director at Amedica Corporation. Mr. Truetzel has been the general partner of Augury Capital Partners, a private equity fund that invests in life sciences and information technology companies, which he co-founded in 2006. Mr. Truetzel is a director of Enterprise Bank, Inc., Verifi, Inc., a provider of electronic payment solutions, Clearent, LLC, a credit card processing provider, and Paranet, LLC, an IT services provider. Mr. Truetzel holds a B.S. in Business Administration from Saint Louis University and an M.B.A. from The Wharton School.
How old is David Truetzel?
David Truetzel is 58, he's been the Independent Director of SINTX Technologies Inc since . There are 5 older and 4 younger executives at SINTX Technologies Inc. The oldest executive at SINTX Technologies Inc is Dr. Bryan J. McEntire MBA, Ph.D., 69, who is the Chief Scientific Officer.
What's David Truetzel's mailing address?
David's mailing address filed with the SEC is 1885 2100 S, Salt Lake City, UT 84119, USA.
Insiders trading at SINTX Technologies Inc
Over the last 4 years, insiders at SINTX Technologies Inc have traded over $8 worth of SINTX Technologies Inc stock and bought 5,746 units worth $9,998 . The most active insiders traders include David W. Truetzel i David Francis O'brien. On average, SINTX Technologies Inc executives and independent directors trade stock every 413 days with the average trade being worth of $9,564. The most recent stock trade was executed by David W. Truetzel on 29 November 2022, trading 67 units of SINT stock currently worth $8.
What does SINTX Technologies Inc do?
amedica is the only manufacturer of medical grade silicon nitride, an innovative biomaterial technology ideal for use in spinal fusion and across a variety of medical applications. our silicon nitride features a unique nanosurface texture that promotes bone growth and addresses clinical needs by providing excellent imaging capabilities and demonstrating antibacterial characteristics. our interbody fusion devices and pedicle screw systems are designed to benefit both the patient and the surgeon. with the only fda registered and iso 1345 certified silicon nitride medical device manufacturing facility in the world and a strong sales and distribution organization, we are committed to providing innovative healthcare solutions that improve patient quality of life.
What does SINTX Technologies Inc's logo look like?
Complete history of Mr. Truetzel stock trades at SINTX Technologies Inc
SINTX Technologies Inc executives and stock owners
SINTX Technologies Inc executives and other stock owners filed with the SEC include:
-
Dr. B. Sonny Bal J.D., M.D., MBA, Ph.D.,
Chairman, Pres, CEO & Principal Financial Officer -
Dr. B. Sonny Bal,
Chairman, Pres, CEO & Principal Financial Officer -
David Francis O'Brien,
Chief Operating Officer -
Bryan McEntire,
Chief Technology Officer -
Dr. Bryan J. McEntire MBA, Ph.D.,
Chief Scientific Officer -
Dr. Bryan J. McEntire,
Chief Scientific Officer -
B. Sonny Bal,
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer -
Mike Houston,
Director of Investor Relations and Public Relations -
Jeffrey White,
Independent Director -
David Truetzel,
Independent Director -
Eric Stookey,
Independent Director -
Mark Froimson,
Independent Director -
Michael Marcroft,
Vice President - Business Development -
Dana Lyons,
Vice President - Sales and Marketing -
David O'Brien,
Chief Operating Officer